Journal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Volume 38, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2021.127872
Keywords
5-HT2C agonists; Lorcaserin; Naphthyridine; CNS drugs; Tricyclic amines
Categories
Ask authors/readers for more resources
A series of novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines have been identified as potent and selective agonists of the 5-HT2C receptor. Optimizations on a previously reported series of compounds have led to the discovery of an advanced drug lead with excellent in vitro and in vivo pharmacological profiles.
A series of novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines were identified as potent and selective agonists of the 5-HT2C receptor. Optimizations performed on a previously reported series of racemic tetrahydroquinoline-based tricyclic amines, delivered an advanced drug lead, (R)-4-(3,3,3-trifluoropropyl)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,8]naphthyridine, which displayed excellent in vitro and in vivo pharmacological profiles.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available